Transthyretin sequesters amyloid beta protein and prevents amyloid formation.
The cardinal pathological features of Alzheimer disease are depositions of aggregated amyloid beta protein (A beta) in the brain and cerebrovasculature. However, the A beta is found in a soluble form in cerebrospinal fluid in healthy individuals and patients with Alzheimer disease. We postulate that...
Guardat en:
| Publicat a: | Proc Natl Acad Sci U S A |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
National Academy of Sciences
1994
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC44607/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8078889/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.91.18.8368 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
